From: Inhibition of microRNA function by antimiR oligonucleotides
miRNA | Model | antimiR chemistry | Administration route | Phenotype | Reference |
---|---|---|---|---|---|
miR-122 | Chow-fed mice | Cholesterol-conjugated 2'-O-Me antagomir | i.v. | Lowering of serum cholesterol | [104] |
miR-122 | DIO mice | 2'-MOE | i.p. | Lowering of serum cholesterol | [106] |
miR-122 | Chow-fed mice | LNA | i.v. | Lowering of serum cholesterol | [96] |
miR-122 | DIO mice, African green monkeys | LNA | i.p., i.v. | Lowering of serum cholesterol | [90] |
miR-122 | HCV-infected chimpanzees | LNA | i.v. | Suppression of viremia | [107] |
miR-10b | Mouse mammary tumor model | Cholesterol-conjugated 2'-O-Me antagomir | i.v. | Suppression of lung metastases | [123] |
miR-132 | Orthotopic mouse model of human breast carcinoma | 2'-O-Me | Vessel-targeted nanoparticle delivery i.v. | Reduction of angiogenesis and tumor burden | [124] |
miR-199b | Mouse model of heart failure | Cholesterol-conjugated 2'-O-Me antagomir | i.p. | Inhibition and reversal of cardiac hypertrophy and fibrosis | [125] |
miR-328 | Mouse model of atrial fibrillation | Cholesterol-conjugated 2'-O-Me antagomir | i.v. | Normalization of atrial fibrillation | [126] |
miR-21 | Mouse model of lupus | LNA | i.v., i.p. | Amelioration of autoimmune splenomegaly | [115] |
miR-17-5p | Mouse xenograft model of neuroblastoma | Cholesterol-conjugated 2'-O-Me antagomir | Intratumoral injection | Inhibition of tumor growth | [127] |
miR-103/107 | DIO and ob/ob mice | Cholesterol-conjugated 2'-O-Me antagomir | i.v. | Improved glucose homeostasis and insulin sensitivity | [128] |
miR-138 | NOD/SCID mice with hydroxyapatixe implants | LNA | ex vivo | Enhanced bone formation | [101] |
miR-33 | Ldlr-/- mice | 2'-F/MOE | s.c. | Increased serum HDL-C levels, regression of atherosclerosis | [108] |
miR-33 | DIO mice | LNA | i.v. | Increased serum HDL-C levels | [11] |
miR-33 | Chow-fed mice | n.d. | i.v. | Increased serum HDL-C levels | [129] |
miR-380-5p | Orthotopic mouse model of neuroblastoma | LNA, 2'-F/MOE | i.p. | Decreased tumor growth | [130] |
miR-182 | Mouse model of arthritis | LNA | ex vivo | Amelioration of arthritis | [54] |
miR-29c | db/db mice | 2'-O-Me | i.p. | Reduced albuminuria and kidney mesangial matrix accumulation | [131] |
miR-208a | Hypertensive rats | LNA | i.v. | Improved cardiac function and survival during heart failure | [102] |